Stockscreener 앱 받기
7.04
5.25%
-0.39
시장 영업 전:
7.09
0.05
+0.71%
Shattuck Labs Inc 주식(STTK)의 최신 뉴스
STTK|Shattuck Labs Inc|Price:7.430| - TradingKey
Shattuck Labs Inc (STTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
STTK|Shattuck Labs Inc|Price:7.430|Chg%:+0.340 - TradingKey
Shattuck Labs Inc (STTK) Balance Sheet - TradingKey
Shattuck Labs Inc (STTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
STTK Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentFull Year Guidance - dars.gov.et
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday - The Globe and Mail
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday - The Motley Fool
STTK Initiated Coverage by JP Morgan -- Rating Set at Overweight - GuruFocus
This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday - Benzinga
JPMorgan Initiates Shattuck Labs at Overweight With $10 Price Target - marketscreener.com
JPMorgan reiterates Shattuck Labs stock rating on DR3 program By Investing.com - Investing.com Canada
JPMorgan reiterates Shattuck Labs stock rating on DR3 program - Investing.com
Shattuck Labs Inc (STTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Redmile Group, LLC Increases Stake in Shattuck Labs Inc - GuruFocus
Shattuck Labs Inc. (STTK) Drops Sharply as Biotech Sector Faces HeadwindsIron Condor Alert - dars.gov.et
STTK Initiated Coverage by Leerink Partners -- Rating Set to Out - GuruFocus
Form 13D/A Shattuck Labs For: 20 July By Investing.com - Investing.com Nigeria
STTK stock trades steady as Shattuck Labs highlights cash position and clinical progress - Ad-hoc-news.de
Form 13D/A Shattuck Labs For: 17 July By Investing.com - Investing.com Nigeria
Redmile updates 9.9% Shattuck Labs (STTK) stake after July trades - Stock Titan
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline UpdateSlideshow (NASDAQ:STTK) 2026-07-08 - Seeking Alpha
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock By Investing.com - Investing.com Nigeria
Shattuck Labs CTO Abhinav Shukla sells $2,874 in company stock - Investing.com
Form 4 Shattuck Labs Inc For: 7 July By Investing.com - Investing.com Nigeria
Shattuck Labs (STTK) CTO exercises options and makes small 10b5-1 sale - Stock Titan
Shattuck Labs outlines its oncology platform as investors assess long-term prospects - ad-hoc-news.de
STTKShattuck Labs Inc Options - Finviz
STTK Q1 2026 Earnings: Narrower-Than-Expected Net Loss Boosts Investor SentimentRevenue Warning Signal - dars.gov.et
Shattuck Labs focuses on immunotherapy pipeline as investors watch clinical milestones - Ad-hoc-news.de
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Shattuck Labs cmo Pandite sells $210,300 in company stock - Investing.com UK
Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock By Investing.com - Investing.com South Africa
Form 4 Shattuck Labs Inc For: 2 July By Investing.com - Investing.com Canada
Shattuck Labs cmo Pandite sells $210,300 in company stock By Investing.com - Investing.com Australia
Abhinav Shukla, Shattuck Labs CTO, sells $166,131 in stock - Investing.com
Shattuck Labs (NASDAQ: STTK) CTO option exercises and 23,465-share sale disclosed - Stock Titan
Shattuck Labs (STTK) CMO sells 30,000 shares under 10b5-1 plan - Stock Titan
Form 144 Shattuck Labs For: 2 July By Investing.com - Investing.com Nigeria
410-share sale reported by STTK insider (NASDAQ: STTK) via option exercise - Stock Titan
Form 144 Shattuck Labs For: 1 July By Investing.com - Investing.com South Africa
Abhinav A. Shukla (STTK) files to sell 100 common shares via Form 144 - Stock Titan
1.97%
0.83%
자본화:
|
볼륨(24시간):